Alzheimer's Disease Analysis Retracted | GenomeWeb

A team of Columbia University researchers has retracted its 2013 Nature paper describing an integrative genomic analysis of Alzheimer's disease. According to the retraction notice, sample numbers, image panels, and data points in the ELISA and subcellular localization studies were "inappropriately manipulated and inaccurate."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.